<DOC>
	<DOCNO>NCT00024037</DOCNO>
	<brief_summary>RATIONALE : Laser therapy may reduce severity symptom speed heal oral mucositis . It yet know laser therapy effective prevent oral mucositis . PURPOSE : Randomized phase II/III trial determine effectiveness laser therapy prevent oral mucositis patient undergo bone marrow transplantation .</brief_summary>
	<brief_title>Laser Therapy Preventing Oral Mucositis Patients Undergoing Bone Marrow Transplantation</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether low-energy laser therapy prevent oral mucositis patient undergo bone marrow transplantation . OUTLINE : This randomize , double-blind , placebo-controlled study . Patients randomize one three treatment arm . Arm I : Patients undergo low-energy laser therapy visible red light ( 650 nm ) daily 15-20 minute begin first day transplant condition regimen continue day 2 bone marrow transplantation . Arm II : Patients undergo low-energy laser therapy invisible infra-red light ( 780 nm ) daily schedule arm I . Arm III : Patients undergo sham laser therapy daily schedule arm I . Patients follow day 3 , 7 , 10 , 14 , 18 , 21 , 24 . PROJECTED ACCRUAL : A total 66 patient ( 22 per treatment arm ) accrue study .</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : At risk develop oral mucositis due toxicity result one following : Preparative chemoradiotherapy Multiple drug conditioning regimens Graftversushost disease ( GVHD ) prophylaxis PATIENT CHARACTERISTICS : Age : Over 12 Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Able carry routine oral care No active oral , viral , bacterial , fungal infection No active uncontrolled oral bleeding would preclude laser therapy PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify Other : Not currently enrol protocol oral mucositis state end point ( e.g. , condition regimen toxicity trial GVHD prophylaxis trial ) No concurrent investigational drug agent prevention treatment mucositis No concurrent photosensitize agent</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>oral complication</keyword>
</DOC>